NO20034741D0 - Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser - Google Patents

Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser

Info

Publication number: NO20034741D0
Authority: NO; Norway
Prior art keywords: deoxypeganine; poisoning; treatment; nervous system; central nervous
Prior art date: 2001-04-24

Application number

NO20034741A

Other languages

English (en)

Norwegian (no)

Other versions

NO20034741L (no

Inventor

Klaus Opitz

Joachim Moormann

Thomas Hille

Frank Becher

Original Assignee

Hf Arzneimittelforsch Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-24

Filing date

2003-10-23

Publication date

2003-10-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7682410&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034741(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-23 Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh

2003-10-23 Publication of NO20034741L publication Critical patent/NO20034741L/no

2003-10-23 Publication of NO20034741D0 publication Critical patent/NO20034741D0/no

Links

WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title 2
VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 title 1
208000015114 central nervous system disease Diseases 0.000 title 1
231100000572 poisoning Toxicity 0.000 title 1
230000000607 poisoning effect Effects 0.000 title 1
230000000506 psychotropic effect Effects 0.000 title 1
239000000126 substance Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Addiction (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20034741A 2001-04-24 2003-10-23 Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser NO20034741D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10119863A DE10119863A1 (de)	2001-04-24	2001-04-24	Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen
PCT/EP2002/004278 WO2002087553A2 (de)	2001-04-24	2002-04-18	Verwendung von desoxypeganin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen

Publications (2)

Publication Number	Publication Date
NO20034741L NO20034741L (no)	2003-10-23
NO20034741D0 true NO20034741D0 (no)	2003-10-23

Family

ID=7682410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034741A NO20034741D0 (no)	2001-04-24	2003-10-23	Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser

Country Status (27)

Country	Link
US (1)	US20040132751A1 (cs)
EP (1)	EP1383503B1 (cs)
JP (1)	JP2004526791A (cs)
KR (1)	KR20030094365A (cs)
CN (1)	CN1638774A (cs)
AR (1)	AR033469A1 (cs)
AT (1)	ATE411024T1 (cs)
AU (1)	AU2002325209B2 (cs)
BR (1)	BR0209125A (cs)
CA (1)	CA2445132C (cs)
CZ (1)	CZ20032788A3 (cs)
DE (2)	DE10119863A1 (cs)
DK (1)	DK1383503T3 (cs)
EA (1)	EA200301134A1 (cs)
ES (1)	ES2316595T3 (cs)
HU (1)	HUP0303921A3 (cs)
IL (1)	IL158383A0 (cs)
MX (1)	MXPA03009766A (cs)
MY (1)	MY135676A (cs)
NO (1)	NO20034741D0 (cs)
NZ (1)	NZ529005A (cs)
PL (1)	PL366845A1 (cs)
PT (1)	PT1383503E (cs)
SI (1)	SI1383503T1 (cs)
SK (1)	SK287214B6 (cs)
WO (1)	WO2002087553A2 (cs)
ZA (1)	ZA200308042B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10354894A1 (de) *	2003-11-24	2005-07-07	Hf Arzneimittelforschung Gmbh	Orale Formulierungen des Desoxypeganins und deren Anwendungen
DE10354893B4 (de) *	2003-11-24	2011-03-10	Hf Arzneimittelforschung Gmbh	Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
ES2360547B1 (es) *	2009-11-02	2012-07-04	Consejo Superior De Investigaciones Científicas (Csic)	Procedimiento de obtención de los alcaloides activos de la planta medicinal peganum harmala y su uso.
US20220265582A1 (en) *	2021-02-24	2022-08-25	Universitätsspital Basel	Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3797494A (en) *	1969-04-01	1974-03-19	Alza Corp	Bandage for the administration of drug by controlled metering through microporous materials
US3742951A (en) *	1971-08-09	1973-07-03	Alza Corp	Bandage for controlled release of vasodilators
US3996934A (en) *	1971-08-09	1976-12-14	Alza Corporation	Medical bandage
US4031894A (en) *	1975-12-08	1977-06-28	Alza Corporation	Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) *	1983-04-27	1986-03-27	Lohmann Gmbh & Co Kg, 5450 Neuwied	Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3843239C1 (cs) *	1988-12-22	1990-02-22	Lohmann Therapie Syst Lts
US5602184A (en) *	1993-03-03	1997-02-11	The United States Of America As Represented By Department Of Health And Human Services	Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
DE19906977C1 (de) *	1999-02-19	2000-06-15	Lohmann Therapie Syst Lts	Desoxypeganin-TTS und seine Verwendung
DE19906974C2 (de) *	1999-02-19	2003-10-09	Lohmann Therapie Syst Lts	Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE19906975B4 (de) *	1999-02-19	2004-04-15	Lts Lohmann Therapie-Systeme Ag	Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906979B4 (de) *	1999-02-19	2004-07-08	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19924951B4 (de) *	1999-05-31	2004-02-05	Lts Lohmann Therapie-Systeme Ag	Verwendung von Desoxypeganin zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
WO2001032115A1 (en) *	1999-11-04	2001-05-10	Xel Herbaceuticals	Transdermal administration of huperzine

2001
- 2001-04-24 DE DE10119863A patent/DE10119863A1/de not_active Withdrawn
2002
- 2002-04-18 CZ CZ20032788A patent/CZ20032788A3/cs unknown
- 2002-04-18 JP JP2002584899A patent/JP2004526791A/ja active Pending
- 2002-04-18 BR BR0209125-9A patent/BR0209125A/pt not_active IP Right Cessation
- 2002-04-18 CA CA002445132A patent/CA2445132C/en not_active Expired - Fee Related
- 2002-04-18 EP EP02758191A patent/EP1383503B1/de not_active Expired - Lifetime
- 2002-04-18 CN CNA028088891A patent/CN1638774A/zh active Pending
- 2002-04-18 DE DE50212901T patent/DE50212901D1/de not_active Expired - Lifetime
- 2002-04-18 NZ NZ529005A patent/NZ529005A/en unknown
- 2002-04-18 ES ES02758191T patent/ES2316595T3/es not_active Expired - Lifetime
- 2002-04-18 DK DK02758191T patent/DK1383503T3/da active
- 2002-04-18 US US10/475,788 patent/US20040132751A1/en not_active Abandoned
- 2002-04-18 PL PL02366845A patent/PL366845A1/xx not_active IP Right Cessation
- 2002-04-18 AU AU2002325209A patent/AU2002325209B2/en not_active Ceased
- 2002-04-18 HU HU0303921A patent/HUP0303921A3/hu unknown
- 2002-04-18 SI SI200230779T patent/SI1383503T1/sl unknown
- 2002-04-18 AT AT02758191T patent/ATE411024T1/de not_active IP Right Cessation
- 2002-04-18 SK SK1316-2003A patent/SK287214B6/sk not_active IP Right Cessation
- 2002-04-18 MX MXPA03009766A patent/MXPA03009766A/es active IP Right Grant
- 2002-04-18 PT PT02758191T patent/PT1383503E/pt unknown
- 2002-04-18 WO PCT/EP2002/004278 patent/WO2002087553A2/de not_active Ceased
- 2002-04-18 IL IL15838302A patent/IL158383A0/xx not_active IP Right Cessation
- 2002-04-18 EA EA200301134A patent/EA200301134A1/ru unknown
- 2002-04-18 KR KR10-2003-7013972A patent/KR20030094365A/ko not_active Ceased
- 2002-04-22 MY MYPI20021470A patent/MY135676A/en unknown
- 2002-04-24 AR ARP020101483A patent/AR033469A1/es unknown
2003
- 2003-10-16 ZA ZA200308042A patent/ZA200308042B/en unknown
- 2003-10-23 NO NO20034741A patent/NO20034741D0/no unknown

Also Published As

Publication number	Publication date
MXPA03009766A (es)	2005-04-19
SK13162003A3 (sk)	2004-02-03
AU2002325209B2 (en)	2007-08-16
KR20030094365A (ko)	2003-12-11
US20040132751A1 (en)	2004-07-08
DE50212901D1 (de)	2008-11-27
HUP0303921A2 (hu)	2004-03-01
EA200301134A1 (ru)	2004-04-29
PL366845A1 (en)	2005-02-07
NZ529005A (en)	2007-11-30
HUP0303921A3 (en)	2011-03-28
NO20034741L (no)	2003-10-23
ES2316595T3 (es)	2009-04-16
MY135676A (en)	2008-06-30
CA2445132C (en)	2009-01-13
AR033469A1 (es)	2003-12-17
CZ20032788A3 (en)	2004-05-12
PT1383503E (pt)	2009-01-07
ATE411024T1 (de)	2008-10-15
IL158383A0 (en)	2004-05-12
CA2445132A1 (en)	2002-11-07
JP2004526791A (ja)	2004-09-02
EP1383503A2 (de)	2004-01-28
CN1638774A (zh)	2005-07-13
WO2002087553A3 (de)	2003-02-27
EP1383503B1 (de)	2008-10-15
SK287214B6 (sk)	2010-03-08
DK1383503T3 (da)	2009-02-16
WO2002087553A2 (de)	2002-11-07
ZA200308042B (en)	2004-02-04
DE10119863A1 (de)	2002-11-07
SI1383503T1 (sl)	2009-04-30
BR0209125A (pt)	2004-07-27
HK1062402A1 (zh)	2004-11-05

Publication	Publication Date	Title
EE200100441A (et)	2002-12-16	Monoamiinide taasomastamise inhibiitorid kesknärvisüsteemi haiguste raviks
PT2266594E (pt)	2015-08-05	Vegf para utilização no tratamento de distúrbios do sistema nervoso central
NO20043085L (no)	2004-07-13	Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
DK1339406T3 (da)	2004-09-27	Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet
IS7941A (is)	2005-07-18	Bensasepínafleiður til að meðhöndla taugasjúkdóma
NO20043237L (no)	2004-08-02	Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
DK1304992T3 (da)	2009-08-10	Topisk gel-fremföringssystem til behandling af hudlidelser
NO20022585L (no)	2002-07-25	Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av forstyrrelser i sentralnervesystemet
IS5113A (is)	1999-07-12	Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
DK1063990T3 (da)	2007-05-21	Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1562932T3 (da)	2007-08-13	4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
NO20031903L (no)	2003-06-25	Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser
EE200300545A (et)	2004-02-16	4-(fenüülpiperasinüülmetüül)bensamiidi derivaadid, nende valmistamine ja kasutamine valu, ärevuse ja seedetrakti häirete ravis
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
EP1625207A4 (en)	2008-11-12	COMPOUNDS FOR THE TREATMENT OF INFLAMMATION, DIABETES AND RELATED DISEASES
DK1491212T3 (da)	2012-10-29	Middel til behandling af søvnforstyrrelser
DE60304695D1 (de)	2006-05-24	7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
EE200300540A (et)	2004-02-16	4-(fenüülpiperidiin-4-ülideenmetüül)bensamiidi derivaadid, nende valmistamine ja kasutamine valu, ärevuse või seedetrakti häirete ravis
NO20055098D0 (no)	2005-11-01	Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
ATE292107T1 (de)	2005-04-15	Verwendung von carbonylaminoderivaten gegen zentralnervensystem-störungen
DK1309322T3 (da)	2006-10-23	Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
IL152688A0 (en)	2003-06-24	Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
NO20034741D0 (no)	2003-10-23	Anvendelse av desoksypeganin for behandling av sykdomsforeteelser i det sentrale nervesystem grunnet forgiftning med psykotropiske substanser
NO20023803L (no)	2002-10-09	Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20032156L (no)	2003-05-13	Behandling av angstforstyrrelser